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ABSTRACT 
 
Transurethral resection of the prostate (TURP) is the gold standard method for surgical 
treatment of benign prostatic hypertrophy. Despite the more recent introduction of 
medical therapies for benign prostatic hypertrophy (BPH), the high efficacy of TURP 
still makes it one of the most common surgical operations worldwide and 
approximately 6,000 such operations are performed every year in Sweden. However, 
this surgical technique is not without problems with per- and postoperative bleeding 
events and TUR syndromes being the most serious ones.  The overarching goal of this 
Thesis was to explore if morbidity in TURP could be further reduced, either by 
pharmacological or surgical interventions.  
Study I was a double-blind, randomized, placebo controlled, multicentre study 
comprising 214 patients. The aim was to determine whether pre-treatment with 
dutasteride reduces surgical blood loss or postoperative complications in patients who 
undergo TURP.  Placebo was compared with dutasteride 0.5 mg/day 2 weeks before 
and after TURP, or 4 weeks before and 2 weeks after TURP. Despite significant 
suppression of intraprostatic DHT, pre-treatment with dutasteride did not result in any 
significant reduction in blood loss during or after TURP or complications afterward 
compared to placebo. Study II & III comprised 202 patients with BPH scheduled for 
TURP. After randomization to either bipolar or monopolar surgery, 185 patients were 
evaluated with respect to blood loss (Study II) and postoperative outcome (Study III). 
In Study II bipolar surgery resulted in significantly lower blood loss (235 ml vs. 350 
ml, P<0.001) and transfusion rates (4% versus 11%, P < 0.01). The latter probably 
explained by the 81 % difference in blood loss for the 75th percentiles (472 ml vs. 855 
ml). In Study III, bipolar surgery was followed by a 16–20% higher percentage of the 
patients reporting ongoing improvement at 3 and 6 weeks after the surgery (P < 0.05). 
There were fewer readmissions in the bipolar group than in the monopolar (5 vs. 13, P 
< 0.05). No differences between the groups with respect to hospital stay and catheter 
duration was recorded. Both bipolar and monopolar TURP resulted in marked and 
sustained improvements of IPSS, bother score, and TM. Study IV was an experimental 
exploration of the in vitro degree of vaporization in bipolar and monopolar resection, 
something previously poorly investigated. Samples of chicken muscle and lamb kidney 
were resected and then desiccated. Results showed that more muscle than kidney tissue 
was vaporized. The fraction of vaporized tissue was significantly higher in the bipolar 
technique. In muscle, the differences between monopolar and bipolar were 17% (P< 
0.05) and 26% (P<0.001) respectively, depending on the type of irrigation used. For 
kidney, the differences were 27% (P< 0.01) and 34% (P< 0.01) respectively.  
In conclusion, no significant reductions in blood loss during and after TURP or 
complications afterward with dutasteride compared with placebo are observed. Bipolar 
TURP significantly reduces the total surgical bleeding, with as much as 81% for the 
largest haemorrhages, as well as the need for erythrocyte transfusions. Postoperative 
readmissions are fewer and postoperative recovery is faster in bipolar TURP. Bipolar 
TURP, results in equally long lasting good results in TM/IPSS and QoL, as in standard 
monopolar technique. Vaporization stands for a further 50% tissue removal during 
conventional resection and is significantly higher in bipolar standard loop resection. 
Bipolar resection devices work satisfactorily in Ringer’s Acetate in an in vitro setting. 
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1 INTRODUCTION 
 
 
TURP is one of the most common surgical procedures in the world. In Sweden alone, 
about 6,000 such operations are performed every year. This is in spite of a decrease 
during the last two decades due to the introduction of more efficient pharmacological 
therapies as well as a range of minimally invasive techniques.1 This decrease in the 
number of TURP procedures can also be seen in Western Europe and in the U.S., 2 
whereas it is increasing in Japan and other Asian countries, and trends in Africa point in 
the same direction.2-6 TURP is still referred to as “the golden standard” in treating BPH. 
An impressive amount of clinical and experimental studies during the last fifty years 
has contributed to maintaining this position, showing undisputable evidence for this 
technique in terms of efficiency, safety and reliability.7,8 Although there still are 
potentially dangerous drawbacks of this method, urologists worldwide favour this 
technique to others. An important reason for this is probably that the technique still 
contains a great deal of surgical craftsmanship and challenge.  
 
Over the years, there have been improvements regarding different aspects of the 
technique. Stricter criteria for surgery have been employed, resulting in fewer 
complications. New irrigating solutions and better monitoring have also contributed to 
the patient’s safety, but this is only valid for the monopolar technique. It was not until 
the mid-1990s, when bipolar TURP emerged in the market, that one really could talk 
about a major change in the way of treating BPH. Suddenly, the surgical procedure was 
based on a completely new electrical principle facilitating the use of ion-containing 
irrigating fluids and with this a reduced risk of TUR-syndrome, symptoms from 
absorption of irrigant, as we know it.  
 
On one hand, we wanted to see whether pre-treatment with a new 5-ARI really could 
make a change in surgery-associated haemorrhage in monopolar TURP by testing it in 
a large, well-designed study. On the other hand, we also wanted to assess the 
aggressively marketed new bipolar technique, which at the time did not have much 
scientific support in terms of randomized trials. Nonetheless, it was said to present a 
safer procedure for the patient with no, or reduced, need to monitor saline absorption, 
as well as a reduced blood loss. 
 
This Thesis aims to summarize the evolution of TURP since the first operations with 
primitive instruments, over the long era of monopolar TURP with non-ionic irrigants to 
the present situation, where we face a future consisting of the bipolar technique with an 
improved safety profile and even further possibilities to increase safety in terms of new 
irrigants with new markers of absorption. 
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2 HISTORICAL REMARKS 
 
 
What we now face in terms of bipolar resection of the prostate can be considered as the 
fourth generation in surgical procedures concerning the relief of symptoms associated 
with BPH. The first generation is the open prostatectomy, 9 the second is the monopolar 
technique, which has gained the status of the golden standard, and the third generation 
is the range of different minimally invasive techniques, including effective drug 
treatments introduced in the 1990s. 
 
At the beginning of the twentieth century, urologists used different kinds of techniques 
and instruments in order to treat the enlarged prostate. However, open prostatectomy 
was by this time considered to be the method of choice to achieve any sustainable 
results. Urologists experimented with a number of concealed knives, cold punches and 
different electrical devices.10 
 
It was not until 1926, when Maximilian Stern tried out the new radio-frequency valve 
diathermy generator invented by Wappler, that loop resection became a real possibility. 
It was then described that the current created a halo around the Tungsten loop, which 
cut the tissue during its advance in the gland. Haemostasis was not great, though, and 
eventually manufacturers combined the old spark-gap technique with the new 
diathermy, providing variable current outputs necessary for both coagulation and 
cutting. 
 
McCarthy added his faroblique telescope to the device, and the Stern-McCarthy 
resectoscope was a fact. This was an instrument that was sturdy and reliable and served 
as the template for instruments of today. The procedure developed rapidly during the 
1930s, and prostates were not considered to be large unless 30 g had been removed. 
 
Nesbit published detailed recommendations on how to perform a TURP in 1943, 11 but 
the method decreased in popularity in favour of open prostatectomy during World War 
II and the years thereafter. This was probably because of the fact that the electrical 
equipment was needed elsewhere, the introduction of better antibiotics and the comfort 
in the field of open surgery that the homecoming surgeons experienced. In addition to 
this, Terence Millin, one of the pioneers in hot wire resection, confided that his TUR 
percentage had decreased from 80% in 1940 to less than 10% at the time for his 
retirement.  Progression was now slow but gained speed when three inventions of 
Harold Hopkins found their way into the pre-existing method. First was the rod-lens 
telescope, developed in collaboration with Karl Storz. The second was the flexible glass 
fibre light, providing excellent illumination. The third was the coordinated flexible 
glass cable, which made it possible for a pupil to watch the operation and thus gave 
good opportunities for education.  
T. Fagerström 
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3 TECHNOLOGICAL DEVELOPMENT 
 
 
INSTRUMENTS AND ELECTRICITY 
 
After various attempts to relieve patients from infravesical obstruction with different 
types of sounds, concealed knives and punches, a definite step towards the present 
technique was taken by Bottini at the end of the 19th century.12 He devised an 
instrument, not unlike a lithotrite, that was heated by direct current and caused the 
blade to burn a channel through the bladder neck.  The procedure was blind, but there 
was no blood loss until the slough came away.  
 
When discovering that high-frequency alternating current did not excite nerve or 
muscle tissues, urologists began to use electric cystoscopes to cauterize neoplasms of 
the bladder and later to burn a channel through the prostate, even though this was a 
time-consuming and inefficient procedure that demanded repeated sittings.13-15 
The next step was to use the cold punch to cut away tissue and the diathermy to stop the 
bleeding. At the same time, development of loop resection was tried but not very 
successful because of the fact that it is difficult to cut tissue with only a hot wire at 
hand. 
 
Further development has already been described, and the Stern-McCarthy resectoscope 
is the prototype of all the present-day instruments. 
 
Today, several different instrument systems are available by different manufacturers. 
There are no great differences between the instruments, more a matter of ergonomic 
and economic features. All systems also have a wide range of interchangeable 
equipment, providing readiness for different urological tasks. 
 
Telescopes are available in different angles starting from 0°. Historically, most 
resectionists have used the 30° lens, a tradition that has its explanation in the early 
instruments, where there was a tiny lamp at the end of the telescope and the lens had to 
be slightly angled in order to provide any vision at all. 
 
The first sheaths were made of Bakelite, then of fibreglass and similar plastics. These 
materials often cracked and split. Nowadays, all sheaths are made of steel, often with 
special surface treatments to spare the urethra. The tip of the sheath is insulated by a 
plastic or ceramic beak. A further development of the sheath was made by Iglesias, 16 
which allows a continuous flow of irrigating fluid, preventing a build-up of pressure in 
the bladder. 
 
Diathermy in transurethral resection has been continuously refined during the years, 
from the first trembling pursuits in the beginning of the 1900s to the advanced 
machinery of today.  
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The general principle for both monopolar and bipolar diathermy is the high-frequency 
alternating current, which does not allow nerve or muscle stimulation since the cell 
membranes are not given enough time to depolarize. In practice, frequencies between 
300 kHz and 5 MHz are used. This makes it possible to pass very large currents 
through the body without causing nerve or muscle excitation, thus providing the 
opportunity to exploit the heating effect at the points of contact with the tissue. 
 
The main difference between monopolar and bipolar techniques is that the former 
requires a neutral electrode to “collect” the current going through the patient’s body to 
form a closed circuit. The neutral electrode must be of standardized size and attached 
properly not to cause electrical burns. The bipolar technique, on the other hand, does 
not need such a device since the returning current goes via the ion-containing irrigating 
fluid, through the instrument itself, and is collected in different ways (Pic. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture1. Different ways to collect the returning current, as designed by different manufacturers, were the 
blue colour represents the returning pathway. 
 
 
 
This feature also facilitates operation in patients with cardiac devices, such as different 
kinds of pacemakers, since the risk of electrical interference is minimal. 
 
In monopolar TURP, cutting is performed with a pure continuous sine-wave current, 
which produces a spark that makes the cells explode. The thin design of the loop 
facilitates this reaction and no coagulation occurs. Coagulation is achieved by short 
bursts of sine-wave current, heating the tissue rather than exploding it. When applying 
the current in a large electrode, there is a risk of cooking the deeper layers of the gland 
and damaging the sphincter. 
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Using bipolar systems, coagulation takes place at a much lower peak voltage of 65-
120V compared with monopolar systems of 500–800V depending on the system used. 
Investigators propose that this lower peak volume of energy will cause fewer irritative 
symptoms post-resection than standard monopolar TUR systems.17,18 In the third study 
of this Thesis we also found that the postoperative recovery was faster in terms of self-
reported IPSS. High-frequency current generated by a bipolar instrument tends to 
remain superficial – Gyrus (manufacturer) reports a 0.5–1mm depth of penetration 
compared with the 3–5mm depth seen in monopolar systems, something that also has 
been shown in independent studies.19,20 The superficial depth aids in avoiding 
unintended stimulation of nearby nerves as seen during monopolar resection, 21,22 even 
though it cannot be completely avoided.   
 
In bipolar electro surgery, the generator produces a high initializing voltage spike that 
establishes a voltage gradient in a gap between the bipolar electrodes. When the loop is 
sufficiently close to tissue, the high bipolar voltage spike arc between the electrodes 
converts the conductive sodium chloride solution into a non-equilibrium vapour layer 
or ‘plasma’ containing energy-charged sodium particles. Once formed, this plasma can 
be maintained at lower voltages. With tissue contact, there is disintegration of tissue via 
molecular dissociation as the current flows to the nearby return electrode. Energetic 
species of the charged ions from the plasma result in disruption of carbon–carbon and 
carbon–nitrogen bonds. There is also electron impact dissociation of water molecules 
into excited fragments of H+ - and OH--ions. Bottom line is the rupture of cell 
membranes, which translates into visible cutting.18 
  
  
IRRIGATING SOLUTIONS 
 
In transurethral resection, the irrigating solutions are used to dilate the operation field 
and to wash away debris and blood in order to gain good vision. Since isotonic 
electrolyte solutions are incompatible with the original monopolar technique, sterile 
water was first employed for irrigation in TUR. In 1947, it was documented that an 
uptake of more than three litres led to overt symptoms of absorption, and the condition 
was called TUR syndrome, first being discovered in such an operation.23,24 This led to 
intense work to make the irrigation safer, and various non-electrolyte solutes were 
added to the fluids to prevent haemolysis-induced renal failure in case of absorption. 
Today, a variety of nonhaemolytic, nonelectrolytic solutions are commercially 
available. Although haemolysis disappeared in the 1950s, other types of serious adverse 
effects still appear, linked to the type of fluid used and, of course, to the fact that the 
volume absorbed in itself can cause severe life-threatening and even fatal TUR 
syndromes.25 
 
Glycine is marketed as a 1.5% solution, which is slightly hypo-osmotic. Glycine is an 
amino acid; elimination takes place by cleavage in the liver, yielding ammonia. 
Absorption may give rise to hyper ammonemic encephalopathy and also to visual 
disturbances and transient blindness due to its properties as a neurotransmitter. When  
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absorbed, it creates a hyperosmotic diuresis which in turn results in an absolute sodium 
loss.  
 
Mannitol is an isomer of glucose, sold in 3% or 5% solutions. Mannitol is excreted 
unchanged in the urine and causes osmotic diuresis. Circulatory symptoms in 
absorption are as common as for glycine, but neurological symptoms are rare.26 
Sorbitol is metabolized into fructose and glucose and may result in lactacidosis.27 If a 
patient is intolerant to fructose, life-threatening reactions can appear. In commercial 
solutions, sorbitol is often combined with mannitol in different ratios. Compared to 
glycine, no difference in symptomatology has been revealed.28 
 
Sterile water, as mentioned above, may cause haemolysis and renal damage if absorbed 
and is thus recommended only for cystoscopic procedures without electrocautery.  
 
Despite these facts, sterile water is still used for transurethral resections worldwide.29-31 
When bipolar electrocautery for TUR emerged on the market, it became possible to use 
electrolyte-containing solutions; therefore, the pattern of side effects has been changed 
in ways that are still partially unknown. Some authors claim that the risk of TUR 
syndrome has now been eliminated.28,32 
 
Normal saline is the only irrigating solution used for this modality so far, but there is 
evidence indicating that other fluids could also be of interest (as shown in Study IV of 
this Thesis). An infusion of saline may give raise to mental changes and swelling 
discomfort, 33 as well as hyperchloraemic metabolic acidosis due to the high chloride 
content.34 
  
 
MONITORING 
 
Alongside technical improvements regarding the instruments for resection, a similar 
development has taken place when it comes to monitoring the patient. The 
anaesthesiologic equipment is now highly advanced and allows for a complete 
surveillance of the patient’s well-being. Several techniques, both invasive and non-
invasive, are now at hand for the anaesthesiologist, a field of knowledge which is best 
discussed elsewhere. 
 
However, there are two issues that deserve a more detailed discussion in this Thesis. In 
TURP, bleeding is the most common incident, and the uncontrolled absorption of 
irrigation fluids is the most feared one.  
 
Bleeding in TURP is an easily overlooked issue since adequate measurement methods 
are rarely applied.35-38 It is not uncommon to hear from urologists that “in my hands” 
haemorrhage is not a problem. Of course, with experience and a good technique, 
bleeding is less likely to cause problems; nevertheless, it is always important to have a 
clear view of the patient’s status during an operation, especially when the patient might 
be fragile due to concomitant medical conditions. 
T. Fagerström 
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Different methods of assessing blood loss are available. They are more or less likely to 
determine true blood loss. Different ways of visually estimating blood loss have been 
applied, methods which have been shown to underestimate the true blood loss by as 
much as 100%.39 The level of potassium after haemolyzation has also been used. 40 
Probably the most widespread way to estimate blood loss to this day is by measuring 
the decrease in blood Hb-concentration.41-44 In Study II of this Thesis we showed that 
precision was poor in assessing blood loss from the fall in blood Hb-levels. The 
problem with these methods is that they indirectly calculate the blood loss, and with 
proven drawbacks, they are frequently not more than very gross estimates and often 
utterly inaccurate. They also give the opportunity to estimate blood loss only 
postoperatively. 
 
In the 1970s, a photometric method of quantitatively determining blood loss was 
developed. This was done with a recalibrated photometer, 39,45 according to the 
formula:  
 
 (g/l)ion concentrat  Hb  blood vePreoperati
(l) volumeirrigant  (g/l)ion concentrat  Hemoglobin Low(l) loss Blood •=  
  
When developing the Low Hemoglobin Photometer, an easily handled portable device 
could be used in the operating room. This created the possibility to continuously follow 
the volume of the blood loss during surgery, which made it easier to decide if, and in 
that case when, to give the patient a blood transfusion. The method was proven to be 
valid in a number of studies with a strong correlation to transfusion rates.46-48 This 
method is routinely applied in Södersjukhuset and in many parts of Sweden, but seldom 
in other parts of the world, where the habit of measuring Hb drop postoperatively clings 
on. 
 
Early in the era of transurethral resection, it was clear that massive absorption of sterile 
water led to severe damage and death. At first, there were no other means of estimating 
absorption than by the volumetric fluid balance, which can easily be misinterpreted by 
the addition of blood and urine to the returning irrigant, spillage on the floor and inter-
bag volume differences.  
 
Dilutional hyponatraemia caused by absorption can be measured quite easily at the end 
of an operation. A good estimate is that a decrease in serum sodium of 5-6 mmol/l 
corresponds to an uptake of 1 litre of fluid.49,50 This method is useless when assessing 
absorption in bipolar surgery, a fact that oddly enough has been neglected in several 
studies comparing bipolar and monopolar TURP.51-55 However, the addition of glucose 
to a concentration of 5% in the saline might serve as a replacement to serum sodium 
concentration measurements.56 
 
There has been at least one attempt to tag the irrigant with radioactive isotopes, but this 
was not in use on a larger scale.57 
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The ethanol method is now the most accurate and well-documented way to measure 
fluid absorption.50,58,59 It is increasing in use, but still the vast majority of studies 
dealing with the evaluation of TURP from different points of view do not apply this 
method. Ethanol is added to the irrigating fluid to a concentration of 1%. The body 
concentration can then be measured in the exhaled breath, using a hand-held 
alcolmeter. The method has a superior sensitivity, detecting approximately 100 ml 
absorption. It is also non-invasive. Another advantage, like the volumetric method, is 
that this makes it possible to determine the amount of fluid absorbed during the surgical 
procedure, thus giving early warnings to stop the operation before a clinically 
significant absorption occurs, preventing TUR syndrome. Ethanol can also be added to 
saline when monitoring bipolar TURP. 
 
The addition of nitrous oxide to the irrigating solution has also been tried with 
promising results experimentally as well as clinically, but it is not in general clinical 
use yet.60-62 
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4 COMPLICATIONS 
 
 
TUR SYNDROME 
 
Symptoms of massive absorption and TUR syndrome occur in between 1-8% of 
TURPs, 7,50,63,64 when at all reported. Most comparable studies are not capable of 
answering questions in this matter because of sample sizes that are too small. 
 
Absorbed fluids find their way in to the body either intravascularly through damaged 
veins or by extravasations through perforated tissues, such as the prostatic capsule or 
the bladder wall. In the former, absorption usually starts in the middle or at the end of 
the procedure and continues until the operation is stopped.65 It has also been shown that 
longer operations and larger resections result in more cases of TUR syndrome.7,65 
 
There seems to be a dose-dependent increase of symptoms associated with absorption, 
best described when using glycine. Typical symptoms during surgery are prickling and 
burning sensations in the face and neck, chest pain, restlessness, and headache. 
Bradycardia and arterial hypotension suggest volume overload and might progress to 
pulmonary oedema. In the postoperative period, patients may present with nausea and 
continuous hypotension, followed by vomiting and low urine production.26,66,67 
Transient cognitive dysfunction is associated with smaller absorbed volumes.68 If the 
absorption is extended to 1-2 litres, apparent confusion with a risk of coma is 
evident.69,70 Abdominal pain is a common first sign of extravasation, which is further 
associated with a higher incidence of arterial hypotension and poor urinary output.71 
Mild TUR syndromes are incomplete and easily overlooked. A drop in arterial 
pressure at the end of surgery combined with postoperative nausea is the most 
common presentation. Severe TUR syndrome is rare and occurs in perhaps 0.1–0.5% 
of operations. A French review of 24 severe cases of TUR syndrome displayed a 
mortality rate of 25%.72 
 
The pathophysiology of the TUR syndrome is complex. When employing non-ionic 
irrigants, absorption can result in a cardiovascular disturbance with an initial increase 
in hemodynamic pressure due to hypervolemia with symptoms such as chest pain, 
dyspnoea and acute pulmonary oedema. This phase levels off within 15 minutes and 
is followed by a decrease in cardiac output, lowered arterial pressure and 
hypovolemia explained by hypokinesia of the heart.73 Bradycardia and ST-depression 
may also be evident because of both the fluid overload and the specific toxicity to the 
heart muscle by the irrigants themselves, 73,74 with glycine being the worst one.74,75 
 
Dilutional hyponatraemia, (<120 mmol/l), which is made worse by osmotic diuresis, 
can create brain oedema and lowered consciousness postoperatively. 
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Swelling of the kidneys is followed by low urinary output, and there is a risk of renal 
impairment and anuria. The causes of death in TUR syndrome are typically 
cardiovascular collapse or cerebral herniation. 
 
The experience of TUR syndromes in surgeries employing saline is still not 
comprehensive, but cerebral oedema is not caused by saline irrigation. However, 
symptoms of fluid overload can still occur. There is also data in dogs suggesting that 
the excess of chloride ions might induce a decrease in the glomerular filtration, which 
in turn can cause a delayed diuretic response to fluid overload.76 
 
The best way to prevent TUR syndrome is to have a good surgical technique, sealing 
bleeders when they appear, avoiding open venous sinuses and, if possible, limiting 
the operation time, even though there is also a risk of massive absorption in the early 
phase of the operation. Keeping the pressure low in the bladder is also a factor that 
affects the incidence of absorption; this can be achieved with either a continuous flow 
resectoscope or a suprapubic trocar, or by frequent intermittent emptying of the 
bladder. Altering the height of the fluid bags does not have any effect in preventing a 
TUR syndrome.77,78 
 
Treatment of TUR syndrome in surgeries involving ion-free solutions include initial 
volume replacement with colloids and infusion of hypertonic saline if symptoms have 
developed or if serum sodium has fallen to below 120 mmol/l. Diuretics have a role if 
pulmonary oedema or renal failure develop but should be carefully used until the 
patient is haemodynamically stable. Massive extravasation into the intraperitoneal or 
periprostatic spaces can be treated with surgical drainage and accompanying 
correction of electrolytes. 
 
 
HAEMORRHAGE AND TRANSFUSION 
 
Bleeding, to various extents, is the most common reason for difficulties during surgery 
as well as for danger to the patient. Attempts to limit blood loss have been made by 
refining the surgical technique, improving electrocautery devices, experimenting with 
preoperative drugs such as 5-ARIs 79-81 and selecting and preparing the patient. Still, the 
amount of bleeding depends on the length of the resection, the amount of the resected 
tissue and the surgeon’s experience.  
 
Erythrocyte transfusions are administered to 0-23% of patients in monopolar TURP 
studies.82-84 In a review of bipolar TURP studies, the transfusion rate was found to be 0-
11% 86. Mamoulakis et al. reported in their meta-analysis that there was a significant 
difference in transfusion rates in favour of the bipolar technique.86 
 
The photometric method of assessing blood loss is infrequently used; therefore, it is 
difficult to compare the findings of our group to the results of others where either the 
loss of blood Hb or the visual estimation method was used. Accessible data on blood 
loss with the photometric method, 46-48 suggests a haemorrhage of approximately 15  
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ml/g of resected tissue. This figure is reproduced in both Study I and II (monopolar 
group) of this Thesis. Added to the lower transfusion rates, the 11.4 ml/g haemorrhage 
in Study II clearly indicates that bipolar resection decreases perioperative blood loss in 
TURP. The rates of haemorrhage-associated complications such as AMI are available 
for monopolar surgery thanks to a series of large studies from the late 20th century  and 
have gradually decreased.7,8,87-89 Data for comparison to bipolar surgery are not yet 
substantial enough, but there are no indications of any higher rate of complications 
linked to blood loss in previously published papers on bipolar TURP. 
 
 
OBTURATOR SPASM 
 
More of a problem in bladder resections, but nevertheless also occurring in TURP, an 
obturator jump can cause severe damage to the patient. Especially when a tumour is 
located on the lateral wall, low frequency diathermy currents can stimulate the 
obturator nerve, resulting in a spasm of the adductor muscles. If the legs are fixed in 
stirrups, this adduction will lead to an elevation of the pelvis, and there is a major risk 
for bladder perforation. Obturator jumps in TURP are not as frequent, but when 
occurring, the surprise effect is potent. Steps to prevent this can be taken, including 
general anaesthesia with complete muscle relaxation, turning down the current, and 
applying a local blockade of the obturator nerve.90,91 
 
With bipolar devices, it seems that the incidence of obturator jumps has 
decreased.22,92,93 The explanation for this is that the return current takes another path in 
a more local circuit.  
 
 
INFECTIONS 
 
The rate of infection following TURP is usually low, ranging in between 0-22% in 
monopolar series, 84,94 with the mean number of cases being around 4%. Preoperative 
bacteriuria (indwelling catheter, bladder stone), prolonged operation duration (>70 
min), long preoperative stay (>2 days) and discontinuation of catheter drainage (due to 
tamponade evacuation) are all considered as risk factors.  
 
Urosepsis is the most serious infectious complication after TURP, often demanding 
intensive care efforts, but fortunately it is not common. Other manifestations are febrile 
or non-febrile lower UTI, and epididymitis.   
 
Several large meta-analyses have found that a general preoperative antibiotic 
prophylaxis significantly decreases the incidence of bacteriuria, lower UTI and febrile 
infections including septicaemia.95,96 This is considered as strong evidence by the 
Swedish Council on Health Technology Assessment of 2010, 97 where a general 
antibiotic prophylaxis in TURP is advocated. The same point of view is expressed in 
the updated EAU guidelines of 2011, 98 where it is shown that antibiotic prophylaxis 
decreases the relative risk for bacteriuria and septicaemia by 65% and 77%, 
respectively.  
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In those analyses of bipolar TURP compared to the monopolar technique, there is no 
evidence of an altered panorama or frequency of infections, even though it seems as if 
trends point to a lower incidence.94  
 
 
CATHETER TIME AND HOSPITALIZATION TIME 
 
It is generally difficult to assess the length of postoperative catheterization and 
subsequent in-patient hospitalization in bipolar TURP compared to monopolar. This is 
mainly due to insufficient or lack of reporting protocols for catheter removal. There are 
examples of removing the catheter on a fixed day, 44 prolonged catheterization for large 
glands, 54 and removing the catheter after urine is completely clear.53,99-104 
 
The length of catheterization is subject to different factors, such as clinical routines, 
interest of caregivers and, inevitably, the amount of blood in the postoperative 
irrigation. 
 
In the literature for both bipolar and monopolar TURP, the length of catheterization 
varies from less than one day up to four days or more.94 
In centres such as our own department, where we routinely remove the catheters as 
soon as possible, differences in catheterization and hospitalization times are seldom 
seen. In other centres where longer catheterization is practiced, differences are 
detectable and in favour of the bipolar technique.86 The difference in hospitalization 
follows the catheterization times; once the catheter is out, the patient is discharged 
shortly hereafter. 
 
 
READMISSIONS AND REOPERATIONS 
 
The rate of re-TUR in different monopolar series is 0-6.6%.84 Madersbacher et al. 
showed that the accumulated re-TURP rate after 1, 5 and 8 years was 2.9%, 5.8% and 
7.4 % respectively.105 In agreement with this, Wasson et al. present a 5-year risk for 
reoperation following transurethral resection of 5%.106 Reoperations also include TUIP 
because of bladder neck contractures, reported to occur in 2-9% of the patients.107 
Bipolar complications of these kinds are likely to be at the same levels, according to 
reported data.94 This is also true for the incidence of urethral strictures, an issue that has 
caused a great deal of debate. 
 
In the beginning of the bipolar TURP era, a few studies reported higher stricture rates 
compared to monopolar operations.36,37,54 The method was therefore seriously 
questioned, and warnings were given. Stricture rates in these selected series were about 
3-6%, which is not statistically different from monopolar groups. The overall stricture 
rates in historical monopolar series have varied from 2.2 to 9.8%.84 Reasons for this 
seemingly higher stricture rate were thought to emanate from the path of the bipolar 
current, causing electrical damage to the urethra. Recently, a number of large studies 
have not been able to reveal any true differences between the two techniques.86,108  
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It seems that there is still reason to believe that by using narrow instruments and 
enough lubrication and limiting the time of operation, one can keep the strictures to a 
minimum. 
 
The introduction of bipolar TURP also seems to reduce the need for immediate 
postoperative interventions such as bladder evacuation due to clot retention and 
secondary coagulation as reported by Ahyai et al.94 
 
 
MORTALITY 
 
There has been a gradual reduction in immediate postoperative mortality over the years. 
From the beginning of the TURP era, Perrin et al. reported a mortality rate of about 
5%.109 Various works then outline the stepwise decrease in mortality 7,110,111 until more 
recent studies, where the 30-days mortality is close to or equal to zero.8,89,112 The debate 
as to whether TURP is associated with an increased long-term mortality was 
thoroughly summarized by Sandfeldt in his Thesis from 2001.113 Here, the direct 
reasons for the slightly elevated risks were not clearly demonstrated, but indices 
pointed towards a significant incidence of comorbidities among the TURP patients. 
Other works have stressed that there are no real differences in either long- or short-term 
mortality when compared to unoperated age-matched control groups.106,114 
 
The decrease in mortality is attributed to a better technique, improved instruments, 
more thorough patient selection, improved antibacterial medication, safer irrigants, 
more careful monitoring and improved postoperative care. 
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5 ALTERNATIVE TREATMENT METHODS 
 
 
MINIMALLY INVASIVE TECHNIQUES 
 
A range of different minimally invasive methods have found their way into the arena of 
treating BPH. Why? one could ask, since TURP has proven to be a very efficient 
treatment option with a long-lasting reduction of symptoms that is performed in a more 
and more safe fashion with fewer and fewer complications. But when examining the 
aspect of day-care, the concept of TURP has been less successful, and it is in contrast to 
this that we must view the new techniques which, to a higher degree, focus on 
performance in an out-patient setting. 
 
 
Vaporization 
 
Vaporization was first described in 1995 by Kaplan et al.115 By adding more energy 
than in the regular TURP, it was possible to vaporize the adenoma of the prostate with 
special loops and rollers. The method was time-consuming, though, and it was also 
associated with a higher degree of postoperative retention, impotence and 
incontinence.116 
 
The method has experienced a renaissance since the introduction of the bipolar 
technique, where vaporization is an option with all major bipolar systems, by the use of 
specific electrode designs. There are an increasing number of studies showing that this 
modality produces positive results comparable to TURP both in symptom relief and 
complication rates.94,117,118 Vaporization advocates often point out that the method is 
virtually bloodless, but it is not always clear how this is monitored. However, results 
indicate shorter postoperative catheterization, fewer blood transfusions and shorter 
hospital stays.43,52,119  
 
An important issue to bear in mind when discussing vaporization is that this technique 
does not provide a histological specimen. Incidental prostate cancer is discovered in 
roughly 1 out of every 10 TURPs.120,121 Not all of these are clinically relevant, but the 
possibility of cancer must be carefully considered and discussed with the patient 
whenever choosing between methods that may be unable to give a correct diagnosis. 
 
 
Lasers 
 
Different kinds of lasers have been used, but the two most widespread methods are 
KTP (Potassium-Titanyl-Phosphate, “green light laser”), which reduces prostate 
volume by coagulation, and the Holmium laser that either evaporates or cuts through 
the tissue in an enucleative way. When enucleating the prostate with the Holmium  
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laser, a morcellator is needed to disperse the tissue in order to pass it through the 
urethra.  
 
Several comparisons to TURP have been made, and both methods are successful in 
lowering IPSS-scores (KTP < Holmium < TURP), but overall complication rates are 
higher in both laser methods than in either bipolar or monopolar TURP.94 
 
However, lasers are also undergoing development, and different combination lasers are 
emerging, designed for both coagulation and vaporization as well as for stone 
disintegration in the upper urinary tract. 
 
 
TUMT 
 
Early transrectal microwave treatments were outranged when transurethral antennas 
were developed. New cooling systems with intricate thermo sensors were applied in 
order to protect the rectal wall and the urethra while heating the prostate up to 70° C. 
Today the devices provide the performer with dynamic reports of cell kill and 
temperatures of the treated area, supplying a custom-made treatment. Heating of the 
prostate results in a coagulative necrosis of the prostatic tissue, that is later resorbed, 
thus decreasing the prostate volume.  
 
Outcomes after TUMT are comparable to those after TURP regarding symptom relief 
and rates of complications.122,123 However, flow improvement is lower and retreatment 
rates are higher, as several studies show a range from 19.8% to 84.4% after 5 years. 
Low-energy TUMT displays more disappointing results than the high-energy 
version.124-131 TUMT is said to be a good and safe treatment for those unfit for other 
surgical procedures, unless the patient has a prominent middle lobe.129 Common 
complications include urinary retention, infections, perineal discomfort and urinary 
urgency. An advantage of this method is that it is truly a day-care intervention, since it 
can be done under local anaesthesia. 
 
 
TUNA 
 
Like the TUMT procedure, TUNA delivers heat to the prostate. This is achieved by 
inserting needles transmitting radio-waves creating heat-induced coagulation necrosis. 
Retreatment rates are much higher than in TURP,132 and improvements in symptoms 
and flow significantly lower. It has similar side effects as TUMT. Long-term 
evaluations are not yet available.  
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PHARMACOTHERAPY 
 
With an increasing proportion of ageing men in the Western world, the need for 
efficient treatments of BPH has led to the development of different pharmacological 
regimes. Drugs are now considered the first line treatment for mild to moderate 
symptoms due to BPH and have proven to be very efficient in postponing or even 
avoiding surgery. Two separate mechanisms of action are predominant, and 
combinations of these are frequently used. 
 
 
Alpha blockers 
 
Alpha blockers were originally developed as anti-hypertensives. They also lower the 
tone of the smooth muscles in the urinary tract by blocking different subsets of the α1-
receptor and thus reducing the dynamic component of the bladder outlet obstruction. 
The effect of alpha blockers is dose-dependent, with increasing side effects, such as 
hypotension, vertigo and headache.  
 
Alpha blockers decrease IPSS by 3-4 points and increase flow by 2-4 ml/s. The chance 
of being catheter-free following an episode of acute urinary retention increases by 
about 50 % if an alpha blocker is given 2-5 days before removing the catheter.133 In the 
large MTOPS-study, 134 alpha-blockers alone reduced the risk for surgical intervention 
for two years and then leveled with the placebo arm. 
 
 
5-Alpha Reductase Inhibitors 
 
In castrated patients, the prostate ceases to grow. This indicates the need for androgens 
in the growth of the prostate. Testosterone is converted into the active metabolite 
dihydrotestosterone (DHT) by the two iso-enzymes of the enzyme 5-alpha reductase. 
Finasteride blocks 5-alpha reductase 2, while dutasteride is a dual blocker.  
 
Both drugs have shown long-term effects in preventing progression and improving 
symptoms.135-137 Side effects include loss of libido, erectile dysfunction and 
gynecomastia. Combinations of 5-ARIs and alpha blockers have shown even better 
results than for either of the drugs alone.134 
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6 OBJECTIVES OF THE STUDIES 
 
 
PAPER I 
 
To determine whether 2-4 weeks of pre-treatment with dutasteride, a dual 5 α-reductase 
inhibitor, reduces surgical blood loss and/or postoperative complications in patients 
with benign prostatic hyperplasia who undergo transurethral resection of the prostate. 
 
 
PAPER II 
 
To compare bipolar resection with the conventional monopolar TURP with respect to 
perioperative parameters, such as blood loss, transfusion rate and speed of resection. 
 
 
PAPER III 
 
To compare bipolar resection with the conventional monopolar TURP, focusing on 
peri- and postoperative complications, re-admission rates, reoperations, speed of 
recovery and long-term outcome. 
 
 
PAPER IV 
 
To determine and compare the in vitro degree of vaporization in bipolar and monopolar 
resection in different kinds of tissue, different fluid environments and with different 
kinds of loops.  
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7 ETHICAL CONSIDERATIONS 
 
 
Ethical permits   Paper I: 140/03 (KI, Forskningskommitté Syd, Huddinge           
Universitetssjukhus F59) 
 
Papers II and III: 2005/576-31/1 (Regionala etikprövningsnämnden i 
Stockholm) 
 
All patients gave their written informed consent before entering the studies. 
Participating in the studies did not delay the scheduled surgery. Additional blood 
samples were taken for research purposes, but not to an extent that would affect them 
haemodynamically. Each patient could terminate his participation without further 
notice. In study I, participating patients were subject to more out-patient visits than in 
the normal clinical routine. In study III, the patients were asked to fill in forms of 
IPSS/QoL and timed micturition four times postoperatively, which is three times more 
than in the clinical routine. 
 
In study IV, no ethical permit was necessary, since the studied tissues were derived 
from neither humans nor experimental animals.  
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8 STUDY SUMMARIES 
 
 
MATERIALS / PATIENTS AND METHODS 
 
Study Designs 
 
Study I was a randomized double-blind, placebo-controlled multicenter study in 
which 214 men with a prostate volume of ≥ 30 mL were enrolled. The 23 recruitment 
centres were located in Sweden, Denmark, Finland, Norway, the Netherlands and the 
UK. Patients were scheduled for monopolar TURP within a period that allowed 28–
32 days of preoperative treatment with study medication. Exclusion criteria included 
history or evidence of prostate disease other than BPH, previous prostate surgery, 
treatment with any 5ARI within 12 months, requirement for treatment with aspirin or 
NSAIDs during the restricted periods and severe medical conditions. The patients 
were randomized in a 1 : 1 : 1 ratio to one of three treatment groups, where group 1 
received daily placebo for 4 weeks before and 2 weeks after TURP, group 2 received 
placebo for 2 weeks followed by 0.5 mg of dutasteride daily for 2 weeks before and 2 
weeks after TURP, and group 3 received dutasteride 0.5 mg for 4 weeks before and 2 
weeks after TURP.  
 
The primary endpoint was the evaluation of total blood loss during TURP. Secondary 
efficacy outcomes included measures of  late bleeding 4 to 14 weeks after TURP, and 
the incidence of clot retention, transfusions, acute urinary retention, UTI and urinary 
incontinence after TURP. Throughout the study period, all patients completed a diary, 
recording bleeding events and clots. Every patient visited his urologist repeatedly 
during the 20 weeks of study participation. Blood loss was measured for each bucket 
used to collect irrigating fluid, using the Low Hemoglobin system  (HemoCue, 
Ängelholm, Sweden).39,47,48 Serum concentrations of testosterone and DHT were 
measured on three occasions. The resected prostate chips were also assessed for these 
hormones. Areas of the prostatic urethra and prostatic nodular hyperplasia were fixed 
until incubated with a monoclonal immunohistochemical antibody. After mild 
staining with haematoxylin-eosin, the MVD was determined by microscopy. A 
central laboratory was responsible for all measurements in order to reduce inter-site 
variability for each laboratory variable. 
 
In Study II and III, 202 patients were randomly allocated between 2005 and 2008, 
using a random numbers table, to either TURP using a bipolar system or conventional 
monopolar technique. Inclusion criteria were a TRUS prostatic volume of 30 - 100 mL 
and symptomatic BPH that required surgery. Exclusion criteria were evident prostate or 
bladder cancer, core biopsy of the prostate within 3 months before surgery, signs of 
neurogenic bladder dysfunction or urethral strictures.  
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Monopolar TURP was performed with a Storz resectoscope, using factory-made 
irrigating fluid containing mannitol 3% and ethanol 1%. Bipolar TURP was performed 
with the Olympus TURis system with normal saline solution as the irrigant. To offer 
the same possibility to early detect and quantify fluid uptake in both groups, ethanol 
was added to the saline to the same concentration as in the electrolyte-free irrigating 
fluid 50. Anticoagulation treatments were discontinued prior to surgery. No selection of 
patients to any particular surgeon occurred. General antibiotic prophylaxis was not 
applied. 
 
In Study II, the main outcome measure was blood loss; peri-, postoperative and total, as 
determined by the Low Hemoglobin method. Secondary outcome measurements 
included operating time, bleeding velocity, blood lost per g resected tissue, resection 
radicality and transfusion rate. Factors that could affect results, such as preoperative 
medication, indwelling catheter, surgical treatment and the surgeon’s experience, were 
assessed in subgroup analyses.  
 
In Study III, the postoperative course of the same cohort was investigated. We 
recorded complications, comprising infections and haemorrhage leading to re-
admissions and prolonged hospital stay, as well as reoperations. IPSS/QoL- and TM-
forms were collected preoperatively and at 3 and 6 weeks and at 6 and 18 months after 
surgery.  
 
Study IV was an experimental in vitro study, in which ten samples each of chicken 
muscle and lamb kidney were resected in an isolated container with a fixed volume of 
irrigating fluid. After weighing, the specimen was placed in a plexiglass basin filled 
with 1500 ml of irrigating fluid at room temperature and fixed to a piece of 
Styrofoam (Pic. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture 2. Arrangements  set up for monopolar 
resection of a kidney in the container. 
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Ten cuts in each sample were made. Bipolar resection was performed with the 
Olympus TURis system set at either 280 W (medium loop) or 290 W (large loop) for 
cutting. Saline and acetated Ringers solution were used as irrigants. Monopolar 
resection was performed with a Storz 24 Ch resectoscope with a standard loop, set at 
130 W for cutting. Mannitol 3% was used as irrigant. Container irrigant was changed 
after every five samples. 
 
As tissue chips may absorb irrigating fluid to an unpredictable extent, we desiccated 
reference samples in an incubator to determine the normal water content of the 
tissues. This generated a factor for each tissue, which was used to calculate fresh 
weights from desiccated samples. Fresh, wet and dry weights of the resected samples 
were recorded. 
 
During the period in the incubator, the samples were weighed repeatedly until no 
further weight loss was registered. The difference between the fresh weight of the 
uncut sample and the sum of the fresh weights (calculated based on its expected 
“normal” water content) of the resected tissue and the remains represented the amount 
of vaporized tissue. 
 
 
Statistics 
 
For Study I, the power calculations were based on the study by Donohue et al., which 
showed a benefit of finasteride treatment in reducing perioperative blood loss 
compared with placebo.138 The study had > 90% power to detect a difference in pair-
wise comparisons between each active group and placebo in the primary endpoint using 
a t-test and a general linear regression model with effects for treatment and country. 
Multiple stepwise regression analysis was used to identify significant effects in the 
blood loss model. Complications after TURP were compared using Fisher’s exact test.  
 
Study II and III were designed to detect a difference in total blood loss of 30% 
between the groups, and this was considered the primary endpoint. The other 
measurements in study II, as well as the parameters studied in paper III, were 
considered as secondary endpoints. The Mann-Whitney U test was used to evaluate 
numerical variables with a skewed distribution. Categorical variables were analyzed 
using the x² test. Factors of importance to the blood loss were identified by stepwise 
multiple regression. Two-way ANOVA was used, controlling for factors associated 
with absorption.  
 
In Study IV, all parameters showed a normal distribution. Means were compared with 
independent samples’ t-test. Factors of importance for vaporization were analyzed with 
one-way and three-way ANOVA.   
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RESULTS 
 
 
Study I 
 
Of the 214 patients enrolled, 197 completed the study. (Fig 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Disposition of randomized patients 
 
 
The mean operative duration was 45 min, during which 25 g of prostatic tissue was 
resected. There were no statistically significant differences among the treatment groups 
in the primary endpoint of Hb loss during surgery. As expected, resection weight and 
operating time were significant effects in the blood loss model (P<0.004 and <0.001, 
respectively), but correction of the Hb loss for these variables showed no significant 
differences among the groups. Blood transfusions were given to 1–3% of the patients in 
each group. Two patients required further surgery during the initial hospitalization. 
After initial discharge, an additional three patients were re-admitted as inpatients and 
one as an outpatient. Mean initial hospital stay was 3.1–3.3 days. Excessive and/or 
severe bleeding occurred in relatively few patients per group. No statistically 
significant differences among the groups with respect to perioperative bleeding, defined 
as excessive bleeding, clot retention (requiring intervention), or the occurrence of 
bloody urine and/or clots in the urine as reported by the subject on the diary card, were 
found. In patients treated with dutasteride, no alterations of the MVD in the prostatic 
urethra or regions of nodular hyperplasia were seen, the serum concentration of DHT  
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was decreased by 86-89 %, while the serum testosterone levels were increased by 13-
15 %, and the concentration of intraprostatic DHT was 10 times reduced. These 
findings were all expected. 
 
 
Study II & III 
 
Of 202 randomized patients, 185 eventually were evaluated, 98 patients in the bipolar 
and 87 patients in the monopolar group. There were no relevant differences in base-line 
parameters between the groups (Table 1.). 
 
 
 Operation Technique  
 
                                   Bipolar (n=98)   Monopolar (n=87) 
 
Mean SD n Mean SD n P 
Age (yr) 69.5 7.2 98 72.7 8.4 87 0.007 
Prostate volume (ml) 55.6 18.2 98 58.2 17.6 86 ns 
Hemoglobin pre-op (g/l) 141.0 13.1 98 141.8 14.0 87 ns 
PT-INR 1.1 0.1 98 1.1 0.1 87 ns 
IPSS pre-op (points) 21.7 6.9 31 20.4 7.6 32 ns 
Botherscore 
pre-op (points) 3.9 0.9 31 3.7 1.1 32 ns 
Time Micturition  
pre-op (s/1:st dl) 24.5 14.4 21 27.7 17.9 20 ns 
Indwelling Catheter (n)   33   34 ns 
5-ARI treatment (n)   23   25 ns 
Table 1. Baseline Data Study II and III 
 
 
Operation time tended to be longer in the monopolar group, and resection speed was 
slightly higher in the bipolar group. Resection weight showed no difference between 
the groups. 
 
Per operative, as well as total, blood loss was significantly smaller in the bipolar group 
(P<0.001), a difference that remained when correcting for operating time and resection 
weight. The Hb drop and transfusion rate were significantly lower in the bipolar group 
(P<0.001 and P<0.01 respectively), a fact that has its explanation in the markedly lower 
75th percentile for blood loss in the bipolar group (472 ml versus 855 ml, respectively, 
Fig 2.) 
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Figure 2. Total blood loss in ml expressed as box-plots  
with the median, 25th–75th percentile, and outliers. 
 
 
The difference in blood loss remained also when taking subgroups of patients in to 
account (Table 2.). 
 
 
 
Operation technique Mann-Whitney U 
Bipolar Monopolar  
 Bleeding/g/min Bleeding/g/min  
 n Median n Median P 
All patients 98 0.14 (0.10-0.28) 87 0.23 (0.15-0.33) <0.001 
5-ARI 23 0.13 (0.09-0.31) 25 0.23 (0.17-0.34) 0.007 
Anticoagulants 4 0.11 (0.09-0.14) 9 0.26 (0.19-0.39) 0.014 
Preop indwelling Catheter 33 0.13 (0.08-0.20) 34 0.21 (0.15-0.30) 0.02 
Reuter's trocar 19 0.12 (0.08-0.14) 25 0.19 (0.14-0.30) 0.03 
Residents 9 0.27 (0.09-0.32) 5 0.12 (0.11-0.14) 0.606 
 
Table 2. Study II, Subgroup analyses. Perioperative bleeding/g/min 
(blood loss in ml over number of grams resected over length of 
resection in minutes) expressed as median, 25-75th percentile 
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Stepwise multiple regressions found three factors of importance for predicting blood 
loss: operation time, resection weight and the choice of mono/bipolar surgery (all 
P<0.001). 
 
Absorption of irrigating fluid was detected by the ethanol method in 21 (11%) of the 
patients, with no difference between the groups, even though there was a trend of fewer 
absorptions in the bipolar group. All but one of the absorptions occurred at the end of 
surgery, and ten had a duration of at least 20 minutes. No obturator nerve affection was 
recorded in either of the two groups. The absorption led to symptoms in three 
monopolar patients (drop in arterial pressure and decrease in serum sodium, abdominal 
pain and headache). Two-way ANOVA showed that the incidence of fluid absorption 
was independently associated with a larger surgical blood loss and 15 minutes longer 
operation time (both P < 0.02). 
 
In all, 131 (71%) catheters were successfully terminated within 24 hours, and an 
additional 23 (12%) patients had their catheters permanently removed within 48 hours 
with no inter-group differences. A similar number of patients in the two groups were 
discharged with an indwelling catheter due to failure to void. Only one patient 
(monopolar) did not succeed in the removal of his catheter within the follow-up period. 
The hospital stay was similar in the two groups with a median of 51-52 hours. 
 
The number of readmissions was 14 for monopolar and 5 for bipolar (P < 0.011).  
Readmissions were associated with larger haemorrhage per minute during the resection 
(P < 0.03). Two patients in the bipolar and one in the monopolar group were diagnosed 
with urethral strictures in the follow-up. Of the six patients (3%) who were reoperated, 
two were in the bipolar (2%) and four (5%) in the monopolar group. Reoperations in 
the bipolar group consisted of one urethrotomy and one TUIP, while the monopolar 
group received one TUIP and three re-TURPs performed at 3, 4 and 12 months after 
the initial operation because of incomplete resections. 
 
13 patients in both groups had infections that did not lead to readmission, while one in 
each group did. Most infections appeared within 24 hours of surgery. 
  
A detailed analysis of the IPSS forms showed that recovery occurred faster in the 
bipolar than in the monopolar group, since a larger fraction of the former patients 
reported ongoing improvement at both 3 and 6 weeks (P < 0.05; Fig. 3.). The difference 
was 20% at 6 weeks (P < 0.05). At 18 months, the early differences between the groups 
had levelled out. 
 
 
Study IV 
 
In the reference samples, water content was 73% in muscle and 77% in kidney. This 
means that 1 g of fresh sample corresponded to 0.27 g of dried muscle and 0.23 g of 
dried kidney. In the resected samples, the degree of vaporization was higher in muscle 
than in kidney (P< 0.0001), and it was also higher when using bipolar resection (Table 
3.). 
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Figure 3.  The difference in percentage  
of “Improved” between the groups. 
 
 
 
MUSCLE  AND KIDNEY VAPORIZATION DATA 
 
Monopolar 
Standard 
loop 
Mannitol 
Bipolar 
Standard loop 
Saline 
Bipolar 
Standard loop 
Ringer’s 
Acetate 
Bipolar 
Large loop 
Saline 
Bipolar 
Large loop 
Ringer’s 
Acetate 
 
Muscle 
Vaporization/ 
resected tissue (%) 
45 
(12) 
62* 
(18) 
71*** 
(14) 
41 
(6) 
43 
(5) 
 
Kidney 
Vaporization/ 
resected tissue (%) 
 
22 
(12) 
 
39** 
(15) 
 
56** 
(28) 
 
23 
(10) 
 
22 
(9) 
Table 3. Mean (SD). Pair wise significance comparisons vs. monopolar technique, * P< 0.05, ** P<0.01, 
*** P<0.001 
 
Bipolar and monopolar resection yielded the same degree of vaporization when using 
the bipolar large loop instead of the standard loop. The uptake of fluid into the resected 
chips was quite consistent, regardless of which irrigant used, with about 17% in muscle 
and 12% in kidney. According to one-way ANOVA, the resection method, type of loop 
and choice of tissue were all factors of importance to the vaporization, while the choice 
of irrigant was not. Three-way ANOVA showed that the choice of loop (P< 0.0001), 
fluid (P< 0.03) and tissue (P< 0.0001) were all independently associated with the 
degree of vaporization. No problems in using the bipolar device in Ringer’s Acetate 
were encountered. 
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9 DISCUSSION  
 
 
STUDY I-IV 
 
The most direct and obvious cause of morbidity in TURP is surgical haemorrhage. In 
most operations, this is not a problem, but in a substantial part bleeding is troublesome. 
Massive bleeding leads to increased risks of hemodynamic disturbances. There might 
be a need for transfusions, something that is expensive, not free of risks and could lead 
to immunologic consequences. Because of this, transfusion is usually considered to be a 
complication of TURP. There is also a risk that a massive haemorrhage influences the 
outcome of the procedure. Since there is a considerable number of TURPs performed 
worldwide every year, there are a corresponding number of patients suffering from 
haemorrhage-related sequelae. 
  
The main goal of study I and II of this Thesis was to see whether blood loss during 
TURP could be decreased, either by short-term pre-treatment or with the employment 
of a new technique. 
 
Despite the 86–89% reductions in serum DHT in Study I, neither blood loss during or 
after TURP, nor the incidence of TURP-associated complications differed significantly 
among the treatment groups. The DHT reduction would be sufficient for an effect in 
comparison to other studies with longer treatment including both finasteride and 
dutasteride 139. This study is the largest reported that includes 5-ARI and blood loss. 
The extent of blood loss in the placebo group and a transfusion rate of ≈ 3% were as 
expected from previous reports.7,47 To adjust for variability in operation time 47 and the 
amount of resected tissue, the Hb loss was expressed per amount of resected tissue. 
Still, this did not reveal any intergroup differences. 
 
The thought behind the belief that 5ARIs reduce blood loss during TURP, is that these 
drugs shrink the prostate by reducing the number of blood vessels. This is supported by 
a number of studies from the 1990s showing that treatment with finasteride reduces 
gross hematuria in men with BPH.140-144 However, studies on finasteride and blood loss 
in TURP are less consistent. In four published double-blind placebo-controlled studies 
(including the present), Sandfeltdt et al.48 was not able to confirm that 3 months pre-
treatment with finasteride would reduce blood loss in TURP. On the other hand, 
Donohue et al. showed that finasteride 5 mg or placebo for only 2 weeks before TURP 
resulted in losses of 2.7 and 4.7 g Hb/ g resected tissue, respectively.138 This was not 
seen in the present study, and might be explained by the fact that the blood loss in the 
placebo group was unusually high compared to other studies.47 Yet another multicentre 
study by Boccon-Gibod et al., 145 examining the effects of pre-treatment with 
dutasteride or placebo for four weeks, did not show any differences between treatment 
groups. Other recent and less robust studies have generated further differing 
results.48,79,80 A few studies have shown a  possible benefit by treating with 5-ARI for 
larger resections with resection weight > 30 g.48,146 
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The lack of observable effect on prostatic tissue MVD was expected since previous 
studies have indicated that such an effect appears at a minimum of six weeks of 
dutasteride treatment.147,148 
 
In Study II, bipolar TURP resulted in 34% less bleeding during the operation. When 
comparing the 75th percentile for blood loss, the difference was as high as 81%. This 
also resulted in significantly fewer erythrocyte transfusions in the bipolar group. It is 
our belief that such a reduction is an important advantage, since every step taken to 
limit the haemorrhage benefits both the patient and the surgeon.  In all other recorded 
perioperative measures, bipolar TURP showed similar results to the monopolar 
technique. 
 
The postoperative blood loss amounted to only 3.4% of the total blood loss, with no 
difference between the groups. Thus, it is clear that that the great difference in blood 
loss was limited to the ongoing surgical procedure. The reason for this lower 
haemorrhage is not fully known, but a possible explanation could be that the 
coagulation depth of the bipolar device exceeds the diameter of the microvessels in the 
prostate.20 
 
Most previous assessments of blood loss in bipolar TURP have shown inconclusive 
results. Some have used the decrease in Hb levels, 53,149 others visual analogue scales 99 
or indicator dilution.54 The common feature for these studies is that they give only an 
indirect estimation of the blood lost estimations that may be influenced by several 
unknown factors. Neither do they say anything about the postoperative blood loss, 
which in this study was found to be low in both groups, a parameter of value in the 
discussion of when to terminate the postoperative catheterization. 
 
The concept of measuring the blood loss with the Low Hemoglobin Photometer has 
been proven to be an objective, reliable and easy method.39,47 In spite of this, adequate 
measurement methods rarely are applied in these kinds of studies. To use transfusion 
rate as an index for blood loss is a poor substitute, since transfusion trigger levels varies 
between caregivers and involve a subjective evaluation of health status.  
 
The most widespread method to estimate blood loss is to note changes in the patient’s 
Hb levels, something that might be of inferior precision, as shown in this study (Fig 4.).  
(Other means of measuring blood loss are discussed in the monitoring section of this 
Thesis) 
 
As in Study I, we were not able to show a decrease in surgical haemorrhage among 
patients treated with 5-ARIs. 
 
Study III revealed a faster postoperative recovery in the bipolar group, based on the 
fact that a larger fraction reported early improvements in IPSS and QoL-scores. Bipolar  
 
TURP was also followed by fewer readmissions, especially when caused by late 
hematuria. 
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Figure 4. Blood loss as measured in recovered irrigating fluid versus the change in blood 
Hemoglobin concentration from before surgery until it was completed. The coefficient of 
determination for the linear relationship (r2) is 12%. 
 
 
 
The result of this study is somewhat difficult to view in perspective, since most of the 
previous studies comparing these two techniques have rendered inconclusive results, 
due to too small sample sizes 85,86 and a mix of techniques.37,43,149-151 Readmission rates 
are seldom reported; therefore, our 10 % rate is tricky to interpret when comparing to 
other studies. There was a significantly lower incidence of readmissions in the bipolar 
group (5% vs. 16%). This figure is not easy to compare because of its unique nature in 
this field.  
 
However, our reoperation rate is comparable to those previously reported.37,43,84,94,152 
Our practice of not giving all patients antibiotics before surgery might explain why our 
incidence of infection is slightly higher than that reported by others 94. 
 
We show a markedly shorter catheterization time than several other studies.37,53,54,85 
This  probably reflects matters of clinical routines and traditions as well as different 
interests between private and public caregivers. There is little or no evidence supporting 
a need for prolonged postoperative catheter treatment, in particular as the median 
postoperative haemorrhage is very low in both methods (shown in Study II of this 
Thesis).  
 
There is a debate about whether bipolar TURP is associated with a higher incidence of 
urethral strictures 85 while several studies suggest that there might not be a real 
difference between the two methods.41,86,108 The number of patients developing 
strictures within the study period was too low to allow any comparisons between the 
methods. We believe that in keeping the operation short, limiting the use of wide 
instruments and trying to shorten the postoperative catheterization, we will continue to  
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have a low incidence of urethral strictures in comparison to others.85 By not applying a 
general antibiotic prophylaxis, we experienced a higher incidence of infections after 
TURP. 
 
A potential limitation of both study II and III is that operations were performed by a 
heterogeneous group of surgeons, including residents. This “every-day” situation is a 
reality at most urological departments, but in spite of this our team obtained similar 
results regarding surgical efficiency and postoperative outcome as in previous studies 
that included operations performed only by highly experienced urologists.6,41,44 
 
The formation of subgroups is another possible limitation; however, analyses of our 
key findings with respect to the differences in blood loss were not explained by this 
fact. 
 
Study IV showed that approximately 50 % more tissue disappears than indicated by the 
weight of the resected tissue in bipolar resection. Thus, one can expect around 1.4-1.7 g 
of total tissue loss when resecting 1 g, depending on the type of tissue, resection 
method and choice of loop. When using the bipolar large loop, the results were similar 
to the monopolar technique. The type of irrigating fluid used is of some but limited 
importance. With further developments of the bipolar technique, alternative more 
physiologic irrigants would be of interest. In this context, we demonstrated that the 
device worked without problems in Ringer’s Acetate, with an even higher degree of 
vaporization. 
 
Calculations of vaporization are important when comparing resection methods to open 
surgery in a context of stretching the volume limits of TURP as stated by EAU.98 In 
Study II, we found that the intraoperative blood loss in TURP is substantially lower 
when employing bipolar resection. When taking vaporization into account, the amount 
of blood lost per gram of resected tissue is far below any former reported results of 
TURP-associated bleeding, regardless of the technique used.47,48 Even though the 
degree of vaporization in both bipolar and monopolar TURP has not been thoroughly 
examined, there are indications of vaporization in other studies. Sandfeldt et al. noted a 
difference in TRUS volume corrected to resection weight, pointing towards a 
vaporization rate of 35-67%.48 
 
Bipolar TURP has proven advantages, 41,153 not only in regards to blood loss and 
reduced risk of TUR syndrome, but also when assessing the histological quality in 
resected specimens where coagulation artefacts are less pronounced.19 It facilitates a 
clearer view due to a less-pronounced cautery effect,154,155 which is a contradiction to 
the fact that the coagulation depth in the residual tissue seems to be deeper than in 
monopolar resection.20 
 
The concept of desiccating tissue to decide the true weight of the specimen and the 
water content has been used in several other studies, 156-158 but as this study did not deal 
with prostatic tissue, it is still not clear how the connection to human tissue should be 
made. This is a limitation of the study, but it also gives a suggestion on a usable 
concept when proceeding in future studies engaging the human prostate. 
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GENERAL DISCUSSION 
 
In addition to the argument that bipolar TURP reduces or eliminates the risk of life-
threatening TUR syndrome, we now show that this technique results in a substantially 
reduced surgical haemorrhage, something that might be just as important. Smaller 
surgical haemorrhage with lower transfusion rates and a reduced risk of shock-related 
complications such as AMI, faster recovery and fewer readmissions, are all benefits 
offered to the patients by bipolar surgery. The long-term data confirm that these results 
are as long-lasting as in monopolar TURP. It also benefits the performing surgeon in 
terms of visibility and respecting anatomical landmarks. It might also reduce the stress 
for the performing surgeon, which would be an advantage in a teaching situation. 
 
The impact of reduced bleeding is even more pronounced if surgery in different 
prostate volume intervals is considered. Table 4 illustrates this explicitly (Table 4.). As 
shown here, the results for small prostates are not that different, except for a markedly 
shorter hospital stay in the bipolar group, maybe indicating a more uncomplicated 
postoperative course. But as larger prostates are operated, clear differences between the 
two techniques begin to appear. First, one can note that the amount of blood per gram 
of resected tissue is quite constant in the bipolar group, regardless of prostate size. On 
the other hand, in the monopolar group, the bleeding rate increases drastically with 
prostate size. Here we also have the answer to the difference in transfusion rate 
between the groups. Resection weight, the length of the operation, absorption, 
infections and reoperations do not seem to differ among the volume groups compared 
to the totals. Postoperative catheterization is shorter in the bipolar large prostate group.  
Readmission rates are higher in all monopolar groups, suggesting that this phenomenon 
is associated to the method rather than the size of the prostate.  
 
The incidence of infections following TURP in study III of this Thesis was higher 
than previously reported (14% bipolar, 16% monopolar). This was valid for both 
techniques and was most likely a result of our policy not to apply a general antibiotic 
prophylaxis. Prophylaxis was given only to those with risk factors or a positive 
preoperative urine culture. This has led our department, with support of the 2010 
antibiotic guidelines of the Swedish Council on Health Technology Assessment, 97 to 
change our policy regarding general prophylaxis in TURP.  
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Prostate Size 
All 
(30-100 ml) 
Small 
(30-50 ml) 
Intermediate 
(51-75 ml) 
Large 
(76-100 ml) 
Operation technique Operation technique Operation technique Operation technique 
 
Bipolar 
(n=98) 
Monopolar 
(n=87) 
Bipolar 
(n=45) 
Monopolar 
(n=34) 
Bipolar 
(n=39) 
Monopolar 
(n=38) 
Bipolar 
(n=14) 
Monopolar 
(n=14) 
Total blood loss 
(ml) 
262 399 207 186 278 507 552 969 
Blood loss 
/resected tissue 
(ml/g) 
11 15 11 11 12 20 11 27 
Operation time 
(min) 
60 66 50 54 68 74 82 79 
Resected weight 
(g) 
24 24 17 17 27 29 48 41 
Transfusion (n) 2 10 0 2 0 3 2 5 
Absorption (n) 9 13 3 4 6 7 0 2 
 
Cathetrization 
time (h) 
20 20 20 19 19 19 19 30 
Hospitalization 
(h) 
51 52 33 52 52 52 52 56 
Readmission  (n) 5 14 3 6 2 5 0 3 
Infections (n) 13 13 8 5 5 6 0 2 
Reoperations (n) 2 4 1 1 1 1 0 2 
Table 4. Blood loss, complications and postoperative parameters according to prostate size and choice of 
surgical method. Expressed in median and count as appropriate. 
 
 
If one gives a patient with a prostate size of 100 ml and an expected resection weight of 
50 g (resection weight taken from interval “large” in table 4) a choice of treatment, 
different options are available according to the different elements of this Thesis 
(Table.5).  
 
Extracting data from study I and II, we can say that the bleeding with a conventional 
monopolar technique would be about 750 ml if 50 grams are resected. When adding a 
correction for prostate size, bleeding is greater, about 1350 ml for monopolar 
technique. As stated in study I, no reduction can be seen by pretreating the patient with 
5-ARIs. There is, of course, an option in treating the patient with a 5-ARI in order to 
shrink the prostate and thus decrease the blood loss. Studies show that you have to treat 
the patient for 1-2 years to get a volume reduction of 20-25%.136,159 The same patient 
now has a prostate volume of about 75 ml, and expected monopolar blood loss is about 
600 ml (resection weight 30 g, blood loss 20 ml/g; both extracted from table 4, 
“intermediate” prostate).  
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If, instead, bipolar TURP is considered, we can expect a blood loss of 550 ml with no 
difference if short-term pre-treated. Shrinking the prostate for 12-24 months reduces the 
blood loss to 360 ml, a difference that is most likely clinically insignificant. 
 
The vaporization rate from study IV of this Thesis is yet another factor to take into 
account when assessing TURP-related overall blood loss. The reason for choosing the 
kidney vaporization factor in table 5 is that the water content of the kidney resembles 
that of the human prostate to a greater extent, as shown in a study by Leissner et al.157 
Since the vaporization during TURP of the human prostate is yet unknown, the 
reasoning regarding this must be considered hypothetical.  
 
In Study IV, we had a significantly higher vaporization in bipolar resection. These 
figures suggest a vaporization of about 40% in kidneys resected with bipolar 
instruments and half of that in the monopolar series. The difference was even more 
pronounced when chicken muscle was resected. If employing these figures in table 5, 
the amount of removed tissue is greater than indicated by the resection weight. 
Correspondingly, the blood lost per gram of removed tissue is even smaller. Based on 
the data from Study II and IV, the amount of blood lost is as low as 7.89 ml/g for the 
bipolar technique in the largest prostates. 
 
 
 BIPOLAR MONOPOLAR 
Total Prostate Volume (ml) 100  100 
Expected Resection Weight (g) 50 50 
Expected Blood loss (ml) 550 (11 ml/g) 750 (15 ml/g) 
Expected Blood loss 
corrected for volume (ml) 
550 (11 ml/g) 1350 (27 ml/g) 
Resection Weight  
including Vaporization (g) 
70 (40%) 60 (20%) 
 
Expected Blood loss 
 2-4 weeks Dutasteride Pretreatment (ml) 
550 1350 
 
Prostate Volume,  
after 2 years Dutasteride treatment (ml) 
75 75 
Expected Resection Weight  
Prostate Volume = 75 ml (g) 
30 30 
Resection Weight  
including Vaporization (g) 
42 (40%) 36 (20%) 
Expected Blood loss  
Prostate Volume = 75 ml (ml) 
360 (12 ml/g) 600 (20 ml/g) 
Table5. Different scenarios of blood loss for a prostate with an initial volume  
of 100 ml. 
. 
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A higher degree of vaporization also suggests a more effective procedure in removing 
prostate tissue, which can be of great importance if discussing whether to expand the 
volume limits for TURP or not. There are already voices heard suggesting that the 
bipolar technique is suitable for glands up to 120-130 ml, thus replacing enucleation in 
this volume interval. However, it must be said that the vaporization rate in the human 
prostate remains to be shown, something that will be presented in a forthcoming work 
from our group. Although not statistically significant, there was a higher incidence of 
re-TURPs in the monopolar group of study III (bipolar 0 vs. monopolar 3). 
 
In patients treated two or four weeks prior to surgery with dutasteride, no alterations of 
the MVD in the prostatic urethra or regions of nodular hyperplasia were seen, although 
the serum and intraprostatic concentrations of DHT were sufficiently decreased. 
Correspondingly, the serum testosterone levels were increased. These findings were all 
expected. 
 
Dutasteride has been shown to be effective in reducing intraprostatic DHT within 4 
weeks, but showed no effect of pre-treatment on blood loss during or after TURP, or on 
the complication rate. 
 
The role of 5-ARIs in reducing complications is limited to the volume-reducing effects 
and – possibly – to the use in large glands when regarding blood loss. Even though the 
drug is well-tolerated, it is not without side effects. In combination with the lack of 
effect on blood loss, it does not motivate a long pre-treatment period, particularly not 
when previous works have been unable to discover any benefits of such a regime.  
 
By switching to a modern bipolar system of resection – which in several up-to-date (yet 
mostly small) studies has been proven to reduce the overall complication rate, 
especially in terms of blood loss and TUR syndrome – morbidity is likely to be less of a 
problem. The bipolar systems also have an advantage in that they can be used for 
TURBT, where the superior cutting qualities are much appreciated. The option of 
vaporization in most bipolar systems is yet another feature that secures the future 
survival of this surgical evolution. Versatility is thus provided to an extent that is 
unchallenged by the other minimally invasive techniques. Future research in this field 
includes larger comparisons to different minimally invasive techniques, such as lasers 
and TUMT. Comparisons between the different bipolar systems would also be 
welcomed. There are slight differences in loops, electrical pathways and general 
features that might have an influence on the results.  
 
Considering that TURP is increasing in frequency in the developing world, it is 
tempting to suggest that these countries do not take the detour via the outdated 
monopolar technique, but go straight on to bipolar systems in order to minimize the risk 
of complications.  
 
The “physiologic” properties of saline can be debated. In anaesthesiology, rapid 
infusions of large volumes of saline are never in question. In bipolar resection, ion-
containing irrigants other than saline may be used. Ringer’s Acetate is employed to 
treat shock and replace volume, and the results from study IV in this Thesis indicates  
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that resection works just as well in this environment. Bearing in mind that accurate 
monitoring of irrigating fluids rarely is applied; a development with more physiologic 
irrigants would be welcomed. 
 
Without doubt, the bipolar technique has contributed greatly to making TURP safer for 
the patient and easier for the surgeon. By decreasing the blood loss, decreasing the rate 
of short-term reoperation and readmission as well as minimizing the risk of a life-
threatening TUR syndrome, the method has been taken up as a new standard in our 
department, and it is our belief that bipolar TURP should be considered as the new 
reference standard when comparing techniques for surgical management of BPH. 
 
When adding to this the Ethanol method and the Low Haemoglobin system for 
monitoring absorption and haemorrhage, we have the best and safest concept seen until 
this day to perform TURP. This must be the final conclusion of this Thesis and also the 
answer to the statement outlined in the title.  
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10 CONCLUSIONS 
 
 
 
 Compared with the placebo, no significant reductions in blood loss during and 
after TURP or complications afterward with dutasteride are observed despite 
significant suppression of intraprostatic DHT within four weeks of treatment.  
 
 
 
 Bipolar TURP significantly reduces the perioperative and total surgical 
bleeding by as much as 81% for the largest haemorrhages. 
 
 
 
 Bipolar TURP significantly reduces the need for erythrocyte transfusion.  
 
 
 
 Postoperative readmissions are fewer and postoperative recovery is faster in 
patients undergoing bipolar TURP.  
 
 
 
 Bipolar TURP results in equally long-lasting positive results in TM/IPSS and 
QoL as the standard monopolar technique. 
 
 
 
 Vaporization accounts for a further 50% of tissue removal during conventional 
resection and is, significantly, even higher in bipolar standard loop resection. 
 
 
 
 Bipolar resection devices work satisfactorily in Ringer’s Acetate in an in vitro 
setting. 
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• With a prostate of 100 ml, 12-24 months of treatment with 5-ARI before a 
monopolar TURP still does not result in a blood loss in line with the bipolar 
technique without pre-treatment. 
 
 
 
• There is only a marginal profit in blood loss when shrinking a prostate 
scheduled for bipolar operation. 
 
 
 
• With an assumed two-fold vaporization compared to monopolar resection, 
bipolar surgery is more effective in removing prostatic tissue. 
 
 
 
• Bipolar technology has a consistent blood loss regardless of prostate size, while 
blood loss increases with a larger prostate size and resection weight in 
monopolar operations. 
 
 
 
• If the effect of vaporization is added, blood loss per unit of resected tissue 
decreases in both groups, but the difference becomes even more pronounced 
between the groups, favouring the bipolar technique. 
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11 SAMMANFATTNING 
 
 
Bakgrund 
 
Transuretral prostataresektion, TURP, är fortfarande en mycket vanlig och uppskattad 
”golden standard” metod för behandling av benign prostatahyperplasi (BPH). Trots att 
farmakologiska och minimalinvasiva tekniker förekommer som alternativ så utförs ca 
6000 TURPar varje år i Sverige. TURP utförs knappast polikliniskt då den operativa 
morbiditeten i per- och postoperativa blödningar och ”TUR-syndrom”, som orsakas av 
spolvätskeabsorption, kan kräva särskild uppmärksamhet. Blodtransfusion ges till cirka 
10 % av de patienter som genomgår TURP. En möjlighet att operera med en mindre 
operationsblödning, färre efterblödningar och med en minimering av antalet 
blodtransfusioner är av stort värde. Förbehandling inför TURP med 
hormonmodulerande läkemedel i blödningsminskande syfte har utvärderats vid ett 
flertal tillfällen utan konklusiva resultat. TURP har utvecklats föga på senare år, men nu 
har ett nytt instrument blivit tillgängligt där resektionen sker med bipolär teknik i 
fysiologisk koksaltlösning. Det främsta argumentet för bipolär TURP är att 
användningen av 0.9% NaCl (koksalt) som spolvätska förhindrar det potentiellt farliga 
TUR-syndromet. Det finns också indikationer på att det blöder mindre vid operation 
med bipolära instrument. Blödning under operationen kan kvantifieras mer exakt under 
TURP än vid andra former av kirurgi då allt förlorat blod löses ut i spolvätska.  
 
 
Syfte 
 
Avhandlingens övergripande syfte var att utvärdera om morbiditeten vid TURP kan 
förändras med specifika farmakologiska och tekniska interventioner. Detta studerades 
dels genom att undersöka om förbehandling med en 5-Alfa-reduktashämmare 
(dutasterid) kunde minska blödningen vid konventionell monopolär TURP, dels genom 
att jämföra ny bipolär resektion med konventionell monopolär TURP med avseende på 
blodförlust, per- och postoperativa komplikationer samt långsiktiga resultat. Slutligen 
undersöktes graden av vävnadsförångning (vaporisering) i en experimentell studie av 
både mono- och bipolärt instrument där också funktionen av bipolärt instrument 
testades i en annan spolvätska (Ringer-Acetat). 
 
 
Delstudie I 
 
Denna dubbelblinda, randomiserade, placebokontrollerade, multicenterstudie omfattade 
214 patienter med BPH. Placebo jämfört med dutasterid 0,5 mg/dag 2 veckor före och 
efter TURP, eller 4 veckor före och 2 veckor efter TURP undersöktes. Resultaten 
visade en förväntad och adekvat minskning av dihydrotestosteron i serum hos patienter 
behandlade med dutasterid, men ingen signifikant minskning i blodförlust under eller  
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efter TURP eller komplikationer efteråt med dutasterid jämfört med placebo. 
Blodförlust och transfusion i placebogruppen var lägre än de som tidigare rapporterats i  
studier där relationen mellan 5a-reduktashämmare och blodförlust från prostatan 
studerats. 
 
 
Delstudie II & III 
 
202 konsekutiva patienter från sjukhusets väntelista randomiserades att genomgå TURP 
med antingen ett bipolärt system eller ett monopolärt system. I delstudie II låg fokus på 
att beskriva blodförlust under och efter operation samt transfusionsfrekvens. Delstudie 
III registrerade peri-och postoperativa mätvärden och komplikationer. TM- och IPSS-
formulär insamlades vid 4 tillfällen efter operation. 185 patienter kunde evalueras.  Det 
fanns statistiskt signifikanta skillnader med avseende på den totala blodförlusten, 262 
ml för bipolär och 399 ml för monopolär TURP. Nedgång i Hb-koncentration under 
dagen för operationen var mindre i den bipolära gruppen. Färre patienter i den bipolära 
gruppen transfunderades med erytrocyter (4 % vs. 11 %), något som kan förklaras av 
den mycket lägre 75: e percentilen för blodförlust i den bipolära gruppen (472 ml vs. 
855 ml). I delstudie III noterades att bipolär kirurgi resulterade i fler patienter som 
rapporterade en förbättring vid 3 och 6 veckor efter operationen. Det fanns färre 
återintag till sluten vård i den bipolära gruppen. Inga skillnader mellan grupperna med 
avseende på sjukhusvistelse och kateterbehandlingstid noterades. Bipolär och 
monopolär TURP resulterade i markanta och bestående förbättringar av 
symtomskattning, Quality of Life samt tidsmiktion. 
 
 
Delstudie IV 
 
Referensprover visade att vattenhalten var 73 % i muskel och 77 % i njure. Mer muskel 
än njure vaporiserades. Andelen förångad vävnad var signifikant högre vid bipolär 
teknik. I muskel, var skillnaderna mellan monopolär och bipolär 17 % respektive 26 %, 
beroende på vilken typ av spolvätska som användes. För njure var skillnaderna 27 % 
respektive 34 %. Djupare analys av graden av vaporisering, vid användning av bipolär 
resektion, visade att valet av slynga, typ av vätska och typ av vävnad alla var oberoende 
faktorer som kunde associeras med graden av vaporisation. Bipolär resektion fungerade 
problemfritt i Ringer-Acetat. 
 
 
Konklusion 
 
Förbehandling med dutasterid 2-4 veckor minskar inte blödning i samband med TURP. 
Bipolär TURP minskar per- och postoperativ blödning med upp till 81 %, reducerar 
behovet av erytrocyttransfusioner, resulterar i snabbare läkning och färre återintag.  
Bipolär TURP ger lika långvariga och goda resultat i TM/IPSS och livskvalitet, som 
konventionell monopolär teknik. Vaporisering står för ytterligare 50 %  
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vävnadsminskning under konventionell resektion och är ännu högre vid bipolär 
resektion med standardslynga. Bipolär resektion fungerar tillfredsställande i Ringer-
Acetat in vitro. Förbehandling under 12-24 månader med en 5-ARI i volymsminskande 
syfte hos en patient med en prostatavolym på 100 ml inför monopolär TURP, leder inte 
till en blodförlust i nivå med bipolär teknik utan förbehandling.  
Det finns endast en marginell vinst i blodförlust med att krympa en prostata planerad 
för bipolär operation. Bipolär teknik har en konstant blodförlust oavsett prostatastorlek, 
medan den ökar med större prostatastorlek och resektionsvikt vid monopolär teknik.  
Om vaporiseringseffekten adderas, minskar blodförlust per borttaget gram vävnad i 
båda grupperna, men skillnaden ökar mellan grupperna och gynnar bipolär teknik. 
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